Delivery Order SPE2DR25D2206-SPE2DR26F9FK0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Arimidex 1 mg tablets (30-count packages) with a ceiling value of $11,215.99. This is a firm fixed-price delivery order with an ultimate completion date of November 26, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Arimidex 1 mg tablets in quantities of 30 units, with a ceiling value of $54,381.03. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Arimidex 1 mg tablets (30-count units) with a ceiling value of $9,980.40. This firm fixed-price delivery order, which must be completed by December 12, 2025, represents a non-set-aside, competitively awarded contract under AmerisourceBergen's existing pharmaceutical supply agreement. The vendor, headquartered in Conshohocken, Pennsylvania, will perform work at its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,389.99 on December 8, 2025, for the supply of Arimidex 1 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract is scheduled for completion by December 9, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the contractor's ability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Arimidex 1 mg tablets (30-count packages) with a ceiling value of $44,205.78. This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, represents a non-set-aside competitive award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,648.43 on December 10, 2025, for the supply of Arimidex 1 mg tablets (30-count packages). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by December 11, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-unit package) under a firm fixed price contract with a ceiling value of $1,163.89. This non-set-aside, competitively awarded delivery order is scheduled for completion by November 26, 2025, just one day after the award date of November 25, 2025. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,038.76 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on December 11, 2025. This firm fixed-price delivery order is set to be completed by December 12, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a competitive, non-set-aside procurement executed under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $6,591.89 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Arimidex 1 mg tablets (30-count units) with a ceiling value of $7,294.07. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is scheduled for ultimate completion by December 8, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9FK0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Arimidex 1 mg tablets (30-count packages) with a ceiling value of $11,505.73. This firm fixed price delivery order is scheduled for completion by December 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical supply requirements through open competition. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor serving the military healthcare system, AmerisourceBergen supplies a broad portfolio of brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare programs. The current award for Arimidex, an aromatase inhibitor used in cancer treatment, exemplifies the contractor's role in delivering critical specialty pharmaceuticals to support military medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 12/10/25 |